-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Breakdown: Cytek Biosciences Q4

Benzinga·02/26/2026 21:10:10
Listen to the news

Cytek Biosciences (NASDAQ:CTKB) announced its Q4 earnings on Thursday, February 26, 2026 at 04:05 PM.

Here's a breakdown of the earnings report.

Earnings

Cytek Biosciences missed estimated earnings by -3300.0%, reporting an EPS of $-0.34 versus an estimate of $-0.01.

Revenue was up $4.67 million from the same period last year.

Performance in Previous Earnings

During the previous quarter, the company missed on EPS by $0.03, leading to a 13.22% increase share price change the next day.

Here's a look at Cytek Biosciences's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.01 -0.04 0.01 0.10
EPS Actual -0.04 -0.04 -0.09 0.07
Revenue Estimate 51.25M 46.67M 43.30M 59.38M
Revenue Actual 52.29M 45.60M 51.93M 57.48M

To track all earnings releases for Cytek Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.